If you’ve recently been diagnosed with herpes or are navigating an outbreak, one of the first questions you might have is: how long do herpes symptoms last? Understanding the typical herpes timeline isn’t just about managing discomfort—it’s about gaining control, reducing the risk of transmission, and knowing what to expect.
Early signs like tingling, itching, or redness—often called the prodrome—can appear before any visible sores. Recognizing these early cues gives people a window to start antiviral medication, which can lessen how intense and long an outbreak lasts. Herpes can also spread during periods when no symptoms are visible, a phase called asymptomatic viral shedding. Knowing this helps people take steps to reduce the chance of passing the virus to partners, even when they feel fine.
The timing and intensity of symptoms can vary a lot, especially between a first outbreak and later ones. First episodes are usually the most intense, lasting two to three weeks with widespread sores, body aches, and fever. During this stage, the virus sheds more often and new lesions may keep forming for several days. Recurrent outbreaks, on the other hand, tend to be shorter—often healing in five to ten days—and are usually milder, thanks to the immune system’s memory.
It’s also worth noting the difference between the two main types of herpes simplex virus. HSV-1, which is now a common cause of genital herpes, tends to cause fewer repeat outbreaks and shorter healing times than HSV-2. HSV-2, while more likely to recur and shed without symptoms, doesn’t mean someone will always have frequent or severe flare-ups—everyone’s experience is a little different.
By getting familiar with how herpes symptoms typically unfold, you can better care for yourself, avoid unnecessary worry, and make more informed decisions—whether that’s about treatment, sex, or simply giving your body the time it needs to heal.
The First Outbreak: What to Expect
The first time you experience a herpes outbreak, it can feel overwhelming—but knowing what’s happening and how long it might last can make it easier to manage. For most people, a first episode of genital herpes lasts between two to four weeks. That’s longer than future outbreaks, simply because your body hasn’t built up any immunity yet.
People having a primary infection—meaning they’ve never had herpes before and have no antibodies—often find their symptoms land on the longer end of that range. But even in these early stages, there are patterns to how the body responds and heals.
Day-by-Day Breakdown of Symptoms
Days 1–3: Early Warning Signs
The first few days may come with a tingling or burning sensation, itching, or localized pain around the genital area. These early symptoms, called the prodrome, are your body’s signal that an outbreak is starting. Some people also experience flu-like symptoms, including fever, fatigue, or swollen lymph nodes.
Days 2–6: Blisters Begin to Appear
Next, small fluid-filled blisters—called vesicles—start to form in clusters. They often show up on the genitals, buttocks, or nearby skin. These blisters are fragile and usually rupture quickly, leaving behind open sores that can be very painful.
Days 5–12: Symptoms Peak
This is often the most uncomfortable stage. The ulcers may spread or deepen, and discomfort tends to be at its highest. During this time, the body is shedding more of the virus, and any systemic symptoms like fever or aches may still linger.
Days 10–14: Crusting and Scabbing
As the immune system kicks in more fully, the lesions begin to dry out and form scabs. New sores may still develop, but they’re less common and usually smaller. This is a sign that healing is underway.
Days 14–28: Recovery and Skin Regeneration
In the final stage, scabs begin to flake off, often without leaving scars. For most people, the pain and irritation taper off as the skin heals completely. Starting antiviral treatment early in the outbreak can speed up recovery by a few days and reduce how intense the symptoms feel.
Everyone’s experience is slightly different, but understanding this typical herpes healing timeline can help ease the stress of that first outbreak. The good news? Recurrent episodes are usually much shorter and milder.
Associated Symptoms and Duration
Beyond the visible sores, a first herpes outbreak often comes with systemic symptoms that can make you feel run-down. These signs usually appear in the early stages and can help distinguish a first episode from later, milder recurrences.
Fever, Swollen Lymph Nodes, and Fatigue (3–5 Days)
Fever is one of the most common early symptoms in a primary herpes outbreak. It often starts in the first few days and typically lasts about three to five days. Some people, especially children and young adults, may also experience chills, body aches, and muscle fatigue—sometimes enough to mimic the flu.
Swollen lymph nodes, particularly in the groin or neck, are another hallmark of the body fighting off a new virus. These tend to appear early—within the first or second day—and usually resolve within five to seven days. Fatigue and a general feeling of malaise can last alongside the fever or even linger slightly longer, especially if your immune system is under extra strain.
While most people begin to feel better within a week, some may notice tiredness that continues into the later healing stages. In rare cases, post-viral fatigue may stick around a little longer, particularly for those with heightened immune sensitivity.
Urinary Discomfort (Up to 10 Days)
Pain or stinging during urination is a common symptom, especially when sores form near the urethra. This kind of discomfort can last anywhere from a few days to as long as 10 days, depending on how widespread the lesions are. In women, ulcers on the labia or near the vaginal opening often make urination especially painful. In men, similar discomfort may happen if lesions appear around the tip of the penis or urethral opening.
The good news is that antiviral medications like acyclovir can help ease these symptoms and shorten how long herpes symptoms last, especially when started early.
Recurrent Outbreaks: A Shorter Timeline
After the first herpes outbreak, many people worry that future episodes will be just as intense. The good news is that recurrent outbreaks are typically much shorter and milder, thanks to your body’s immune system recognizing and responding to the virus more quickly.
Typical Duration: Usually 7–10 Days
Most recurrent herpes outbreaks clear up within 7 to 10 days—and often even faster. Because the immune system has already encountered the virus, it can control and limit the infection before it spreads widely. As a result, recurrent lesions tend to be fewer, smaller, and more localized, usually appearing on one side of the body.
With early treatment, especially antiviral medications like acyclovir, famciclovir, or valacyclovir, healing time can be shortened by another one to two days. Even when no visible sores appear, asymptomatic viral shedding may still occur for a few days, which is why some people can unknowingly transmit the virus.
Alongside this shorter timeline, systemic symptoms like fever, fatigue, or body aches are rare during recurrences. Local symptoms—like tingling or burning—are usually milder and more manageable. Many people begin to recognize their own prodromal signs, allowing them to start treatment early and minimize the severity of the outbreak. Over time, both the frequency and intensity of symptoms tend to decrease, especially with consistent self-care or suppressive therapy.
Speed of Symptom Progression
One of the key differences between primary and recurrent outbreaks is the speed at which symptoms move through their stages. Prodromal symptoms like tingling or itching often last less than a day—sometimes just a few hours—before the immune system steps in.
If antiviral medication is taken during this window, it can sometimes stop the outbreak from developing into visible sores altogether. These are known as “aborted” outbreaks. In other cases, short-course antiviral treatments—as brief as a single day—can reduce healing time and help avoid ulceration entirely.
Some recurrent episodes don’t produce any blisters at all. People may feel mild inflammation or discomfort without seeing any lesions. While these outbreaks may feel subtle, they still involve viral activity beneath the surface and can be contagious through asymptomatic shedding.
As your immune system continues to adapt, visible symptoms often become less frequent or disappear entirely. For many people, understanding these patterns brings reassurance—and helps guide better choices around treatment, intimacy, and overall health.
Factors That Can Affect Symptom Duration
Even though herpes outbreaks follow a general pattern, how long herpes symptoms last can vary from person to person. Several factors—ranging from immune health to timing of treatment—can influence the intensity and length of each episode.
Immune System Health
Your immune system is the body’s first line of defense against the herpes virus. People with strong immune responses often experience shorter and milder outbreaks because their bodies are better equipped to contain viral replication.
Proteins called type I interferons play a critical role here—they help the body respond quickly to HSV and limit how far it spreads. When these responses are weakened—either due to health conditions or viral interference—symptoms can last longer.
Genetics also matter. Differences in immune cell activity, particularly regulatory T cells, help explain why some people have more frequent or severe outbreaks, while others rarely notice symptoms at all.
Timing of Antiviral Treatment
When it comes to shortening a herpes outbreak, timing is everything. Starting antiviral treatment at the first sign of a prodrome—those early tingles or mild irritation—can reduce symptom duration by up to two days and sometimes prevent full blister formation altogether.
Delaying treatment until after lesions appear may still help but is often less effective, especially during a first outbreak when symptoms are stronger and more persistent. Quick action gives your immune system a boost and minimizes discomfort.
Oral vs. Genital Outbreaks
The location of the outbreak also influences how long it lasts. Oral herpes, often caused by HSV-1, tends to be shorter and less intense, usually healing within 5 to 8 days. Genital herpes, particularly from HSV-2, typically involves longer episodes, averaging 7 to 10 days, and may include extended viral shedding.
The type of tissue affected and the viral strain both play a role in how symptoms show up and how long they linger.
Suppressive Therapy and Self-Care
For people who experience frequent outbreaks, daily suppressive antiviral therapy can dramatically reduce both how often outbreaks occur and how long they last. While it doesn’t eliminate transmission risk, it does lower the chance of passing HSV to a partner and keeps symptoms in check.
In addition to medication, self-care strategies—like staying well-hydrated, reducing stress, practicing gentle hygiene, and avoiding triggers—can also support faster healing. When combined with antiviral treatment, these habits help you feel more in control and reduce the impact of future outbreaks.
Healing Without Treatment: What to Know
If you’re unable—or prefer not—to take antiviral medication during a herpes outbreak, it’s important to know that the body can heal on its own. Most herpes episodes are self-limiting, meaning the immune system is capable of clearing the virus without medical intervention.
The Body’s Natural Healing Process
For many people, mild to moderate outbreaks will resolve on their own within 7 to 14 days. The immune system plays a key role here, using a coordinated response—including cytokines and T cells—to slow viral replication and help repair the skin or mucosal tissue.
That said, healing without antivirals may take longer, and symptoms can feel more intense. Lesions are more likely to progress from tingling to ulceration, especially during primary infections, and the discomfort can persist until the sores fully scab and regenerate.
Risks of Delayed Healing
While the body can heal independently, untreated herpes outbreaks may carry a few added risks—particularly if lesions are not kept clean or are exposed to ongoing irritation.
- Secondary bacterial infections can develop if open sores become contaminated, which is more common in people with weakened immune systems or if hygiene is compromised.
- Prolonged discomfort is another concern. Lesions that heal slowly or through deeper tissue repair may cause ongoing pain, especially in sensitive areas like the lips or genitals.
- For individuals with immunosuppression, such as those living with HIV, healing may take much longer and the virus can sometimes spread more extensively if not monitored.
Supporting Healing Without Medication
Even if you’re not taking antivirals, there are several ways to care for your body and support faster, safer healing:
- Pain relief is important—not just for comfort, but for reducing stress and allowing rest. Soothing topical treatments like aloe vera, lidocaine, or gentle herbal creams may help ease symptoms without interfering with healing.
- Hygiene matters. Keeping the area clean, dry, and protected helps prevent bacterial infection and reduces the risk of spreading the virus to other parts of the body or to others.
- Minimize trauma to the area. Friction can delay healing or reopen scabbing sores, so gentle clothing and avoiding unnecessary contact are essential.
With proper care and attention, herpes healing without treatment is entirely possible, though it may require more patience and symptom management. Everyone’s body is different—some people may find they heal fairly quickly without meds, while others prefer the faster relief that antiviral therapy can provide.
When Symptoms Linger: What’s Normal vs. What’s Not
Most herpes outbreaks follow a clear pattern and resolve within a couple of weeks. But sometimes, symptoms hang on longer than expected—or appear in ways that don’t quite match the usual picture. Knowing when to wait and when to seek medical advice can help prevent complications and ease anxiety.
Warning Signs of Atypical Healing
If herpes symptoms last longer than 2 to 3 weeks without improvement, it could be a sign that something else is going on. While healing timelines vary, most sores begin to improve within 7 to 10 days and are fully resolved within two weeks. Persistent lesions beyond 21 days, especially without signs of scabbing or healing, may point to issues like a drug-resistant strain or a secondary bacterial infection.
Another red flag is unusual lesion shapes or spread. Deep, linear ulcers or widespread lesions that don’t resemble the usual clusters of blisters may indicate an atypical presentation—especially in people with weakened immune systems.
Lingering pain, burning, or numbness—especially when no sores are visible—may signal nerve involvement. In rare cases, herpes can affect the nervous system and lead to complications like radiculopathy (nerve root inflammation) or encephalitis. These symptoms should always be evaluated by a healthcare provider.
When to Contact a Healthcare Provider
You should reach out to a doctor or clinic if:
- Lesions don’t begin healing within 7–10 days, or start to get worse instead of better.
- You have underlying health conditions that compromise your immune system, such as HIV, recent cancer treatment, or organ transplantation.
- Sores appear in unusual places, like the back, arms, or other non-genital, non-oral areas—this can sometimes point to a different condition that needs confirmation.
Prompt care can rule out complications and ensure you’re getting the most effective treatment, especially during a first outbreak or if symptoms aren’t responding to standard antivirals.
What Can Cause a Prolonged Outbreak?
Several factors may contribute to outbreaks that linger longer than expected:
- Immunosuppression makes it harder for the body to control the virus, often leading to more severe and longer-lasting episodes. People who are immunocompromised may also be at greater risk of the virus spreading beyond the usual locations.
- Acyclovir resistance, while rare, is more common in those on long-term antivirals or with weakened immunity. If a standard medication doesn’t seem to be working, your provider might test for resistance and recommend alternative treatments like foscarnet or cidofovir.
- Incomplete or delayed treatment can also lead to extended symptoms. Starting antivirals late in the outbreak—or not taking them consistently—may limit their effectiveness, allowing the virus to continue replicating and delaying healing.
Timeline of Contagiousness
One of the most important—but often confusing—parts of managing herpes is understanding when the virus is contagious. While most people know that herpes can spread through direct contact with sores, what’s less known is that transmission can also happen when symptoms aren’t visible.
When Shedding Is Most Likely
Herpes is most contagious during an active outbreak, especially when blisters (vesicles) are forming and starting to break open. These early stages involve the highest viral load, making transmission more likely if there’s direct skin-to-skin contact.
But shedding doesn’t stop when the sores fade. The virus can start shedding up to 48 hours before lesions appear, and may continue even after the skin begins to heal. This is why understanding the full herpes outbreak timeline—not just the visible symptoms—is key to reducing the risk of transmission.
People who’ve recently been infected, particularly with HSV-2, tend to shed the virus more frequently, especially during the first year after diagnosis. Over time, the body gains better control, and shedding episodes usually become less frequent.
Symptom Presence vs. Asymptomatic Shedding
A major challenge with herpes is that most transmission happens when there are no visible symptoms. Research shows that up to 70–80% of new HSV-2 infections occur during times when the infected person feels completely normal.
HSV-2 is shed asymptomatically on about 10 to 20% of days, even without an outbreak. HSV-1, when it causes genital herpes, sheds less frequently—on average 3 to 7% of days—and tends to decline faster over time. Still, asymptomatic or subclinical shedding is unpredictable. Even people who’ve never had a noticeable outbreak can still carry and transmit the virus.
Safe Windows for Intimacy and Activity Post-Outbreak
To lower the chance of passing herpes to a partner, it’s best to wait until all sores are fully healed—meaning no scabs, no tenderness, and no signs of irritation. This usually happens about 7 to 10 days after the onset of symptoms.
For added safety, some clinicians recommend waiting an extra 3 to 5 days after healing, since shedding can continue briefly even after the skin looks normal. This may be especially important when partners are new or uninfected.
Daily suppressive therapy and consistent condom use both help reduce the risk of transmission. Antiviral medication like valacyclovir can cut asymptomatic shedding by up to 50%, and while condoms don’t block all skin-to-skin contact, they provide a significant layer of protection.
Understanding how and when herpes spreads can empower people to make confident, informed choices—without fear or stigma. And when you’re aware of the timing, it’s easier to protect both your health and your relationships.
Tips to Support Faster Recovery
While herpes outbreaks usually resolve on their own, there are several ways to support faster healing and reduce discomfort. Whether you’re using prescription treatments or looking for home remedies, these strategies can make a noticeable difference in how long herpes symptoms last and how you feel during recovery.
Early Use of Antiviral Medications
One of the most effective ways to shorten the duration of an outbreak is to start antiviral medication as early as possible—ideally within 48 hours of symptom onset. Drugs like acyclovir, valacyclovir, and famciclovir work by stopping the virus from replicating, which helps minimize how large and painful the lesions become.
For mild outbreaks, topical antivirals can also be helpful. Creams like penciclovir have been shown to reduce healing time and lesion area, even when applied after the initial prodrome stage. Newer options, like acyclovir combined with hydrocortisone (e.g., Xerese™), may offer added benefits by reducing both visible sores and underlying inflammation.
Cooling Compresses and Topical Treatments
Simple comfort measures can go a long way. Cold compresses help soothe pain and reduce swelling, especially in the early days of an outbreak. While they don’t fight the virus directly, they can make symptoms more manageable and slightly limit viral spread by reducing local inflammation.
Natural treatments may also be worth exploring. Lavender cream, for example, has shown antiviral and anti-inflammatory effects in clinical trials—offering a gentle, plant-based option for symptom relief. Over-the-counter creams like docosanol (10%) are another accessible choice; when applied early, they can shorten healing time by blocking the virus from entering healthy skin cells.
Lifestyle Choices That May Help
Your body’s ability to heal is closely tied to your daily habits. Getting enough rest, managing stress, and staying well-hydrated all support a strong immune response. Chronic stress and sleep deprivation are known to trigger herpes recurrences and prolong how long herpes symptoms last, so prioritizing self-care can make a real impact.
Nutritional support may help as well. Foods rich in vitamin C, zinc, and lysine are believed to aid tissue repair and may reduce the frequency or intensity of outbreaks for some people. While more research is needed, maintaining a nutrient-rich diet is a good step for overall wellness.
Finally, try to avoid known triggers like intense sunlight, physical trauma, or surgical procedures—especially near affected areas. Using sunblock, lip balm with SPF, and protective clothing can help reduce flare-ups for those prone to UV-induced outbreaks.
Understanding the Herpes Healing Timeline: What to Take Away
Whether you’re navigating a first outbreak or learning to manage recurrences, one of the most empowering things you can do is understand the timeline of herpes symptoms. Knowing what to expect helps reduce worry, allows for better self-care, and supports safer choices around intimacy and treatment.
A first outbreak tends to be the longest and most intense, often lasting between 2 to 4 weeks, with symptoms like pain, fever, and fatigue. Recurrent episodes are usually shorter—7 to 10 days on average—and milder, thanks to your body’s growing immunity.
Several factors influence how long herpes symptoms last, from immune health and timing of antiviral treatment to the location of the outbreak and whether you’re using suppressive therapy. Even without medication, the body can heal on its own—but proper hygiene, pain relief, and self-care can ease the process. And while the virus can shed even when symptoms aren’t visible, understanding when you’re most contagious helps protect both you and your partners.
Healing, management, and prevention are all possible—and you’re not alone in the process.
Join our mailing list for helpful tips, new research, and compassionate advice delivered to your inbox. Your journey is personal—but you don’t have to navigate it alone.
References
Altaei, T. S., & Ahmed, S. (2012). Topical treatment of herpes simplex lesion by lavender cream. Journal of Baghdad College of Dentistry, 24. Altaei, T. S., & Ahmed, S. (2012). Topical treatment of herpes simplex lesion by lavender cream. Journal of Baghdad College of Dentistry, 24.
Andersen-Nissen, E., Chang, J. T., Thomas, K., Adams, D., Celum, C., Sanchez, J., Coombs, R., McElrath, M., & Baeten, J. (2016). Herpes simplex virus suppressive therapy in HSV-2/HIV-1 coinfected women is associated with reduced systemic CXCL10 but not genital cytokines. Sexually Transmitted Diseases, 43, 761–764.
Bader, C., Crumpacker, C., Schnipper, L., Ransil, B., Clark, J., Arndt, K., & Freedberg, I. (1978). The natural history of recurrent facial-oral infection with herpes simplex virus. The Journal of Infectious Diseases, 138(6), 897–905.
Baldwin, K., & Cummings, C. L. (2018). Herpesvirus infections of the nervous system. Continuum: Lifelong Learning in Neurology, 24, 1349–1369.
Beauman, J. G. (2005). Genital herpes: a review. American Family Physician, 72(8), 1527–1534.
Bella, S. D., Taglietti, F., & Petrosillo, N. (2015). Painful lesions in an HIV-1 seropositive African woman. Journal of Clinical Research, 2, 28.
BeLLO-siLva, M., de Freitas, P. M., Aranha, A., Lage-Marques, J. L., Simões, A., & Eduardo, C. P. (2010). Low- and high-intensity lasers in the treatment of herpes simplex virus 1 infection. Photomedicine and Laser Surgery, 28(1), 135–139.
Bieńkowski, K., Bielaska, A., Wesołek-Bielaska, E., Kołodziej, W., Gałązka, J., & Greszta, M. (2024). Chronic fatigue syndrome related to herpes simplex viruses infection – a narrative review. Quality in Sport.
Burgers, D. C., Pompe, J., Kovacs, I., & Sturm, P. (2015). Widespread HSV-1 infection in ICU patient with respiratory failure.
Chan, T. T., Barra, N., Lee, A. J., & Ashkar, A. (2011). Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa. Journal of Reproductive Immunology, 88(2), 210–218.
Chemaly, R. F., Shafat, T., Wald, A., Kotton, C. N., Papanicolaou, G., Yong, M. K., Miller, V., Komatsu, T. E., Mullick, C., Hodowanec, A. C., Westman, G., Khawaja, F., Birkmann, A., & Ljungman, P. (2025). Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciae638.
Cole, S. (2020). Herpes Simplex Virus: Epidemiology, Diagnosis, and Treatment. The Nursing Clinics of North America, 55(3), 337–345.
Corey, L., Adams, H., Brown, Z., & Holmes, K. (1983). Genital HSV infections: Clinical manifestations and complications. Annals of Internal Medicine, 98(6), 958–972.
Corey, L., Reeves, W., & Holmes, K. (1978). Cellular immune response in genital herpes simplex virus infection. The New England Journal of Medicine. Vol 299(18)
Coyle, P., O’Neill, H., Wyatt, D., McCaughey, C., Quah, S., & McBride, M. O. (2003). Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. Journal of Clinical Virology.
Croll, B. J., Dillon, Z. M., Weaver, K., & Greenberg, M. (2017). Subtle presentation of herpes simplex encephalitis. The American Journal of Emergency Medicine, 35(1), 200.e1–200.e2.
Dhar, J., Carey, P., & Alawattegama, A. (1992). Atypical presentations of herpes simplex virus infection. International Journal of STD & AIDS, 3(6), 442–444.
Eduardo, C., Bezinelli, L., Eduardo, F., Lopes, R., Ramalho, K. M., BeLLO-siLva, M., & Esteves-Oliveira, M. (2012). Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy. Lasers in Medical Science, 27, 1077–1083.
Engin, R. I. (2016). Herpes gladiatorum: A case report. Medicine Science | International Medical Journal, 5, 55.
Epstein, J., Gharapetian, S., Rejali, A., Zabner, R., Lill, M., & Tzachanis, D. (2016). Management of resistant oral HSV following HSCT. Supportive Care in Cancer, 24, 3603–3606.
Esmann, J. (2001). The many challenges of facial herpes simplex virus infection. The Journal of Antimicrobial Chemotherapy, 47(Suppl T1), 17–27.
Fife, K. (2018). Herpes therapy enters the molecular age. The Journal of Infectious Diseases, 218(11), 1689–1690.
Gilbert, S., Corey, L., Cunningham, A., Malkin, J., Stanberry, L., Whitley, R., & Spruance, S. (2007). An update on short-course intermittent and prevention therapies for herpes labialis. Herpes, 14 Suppl 1, 13A–18A.
Graham, J. B., Swarts, J., Mooney, M., & Lund, J. M. (2022). Immunogenetic determinants of HSV-2 infection and disease. The Journal of Immunology.
Griffiths, P. (2004). Interrupting transmission of genital herpes. Reviews in Medical Virology, 14.
Groves, M. J. (2016). Genital herpes: A review. American Family Physician, 93(11), 928-934.
Hsieh, W. B., Chiu, N. C., Hu, K. C., Ho, C. S., & Huang, F. Y. (2007). Outcome of herpes simplex encephalitis in children. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 40(1), 34–38.
Hull, C., & Brunton, S. (2010). The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgraduate Medicine, 122(5), 1–6.
Indra, G., Maragathavalli, G., & Rajendran, D. (2020). Analysis of various treatment modalities of herpetic lesions. International Journal of Research in Pharmaceutical Sciences, 11, 1830–1836.
Kuhls, T., Sacher, J., Pineda, E., Santomauro, D., Wiesmeier, E., Growdon, W., & Bryson, Y. (1986). Suppression of recurrent genital herpes simplex virus infection with recombinant α2 interferon. The Journal of Infectious Diseases.
LeBoeuf, N. R., Lieb, J., & Grossman, M. (2010). Linear erosive HSV: The ‘knife‐cut sign’ in corticosteroid-treated patient. Clinical and Experimental Dermatology, 35.
Leone, P. (2005). Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Current Medical Research and Opinion, 21, 1577–1582.
Leung, D., & Sacks, S. (2004). Docosanol: A topical antiviral for herpes labialis. Expert Opinion on Pharmacotherapy, 5(12), 2567–2571.
Marcu, D., Chele, N., & Motelica, G. (2024). Characteristics of recurrent chronic herpetic stomatitis. Journal of Stomatological Medicine.
Marlina, E., & Soebadi, B. (2013). Management of recurrent oral herpes simplex infection. Journal of Dentomaxillofacial Science, 12, 28.
Meads, D., McKenna, S., Bonney, M., & Bloch, M. (2009). Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist. Value in Health, 12(2), 397–400.
Melvin, A., Mohan, K., Vora, S., Selke, S., Sullivan, E., & Wald, A. (2021). Neonatal herpes simplex virus infection: Epidemiology and outcomes in the modern era. Journal of the Pediatric Infectious Diseases Society.
Mertz, G. J., Benedetti, J., Ashley, R., Selke, S., & Corey, L. (1992). Risk Factors for the Sexual Transmission of Genital Herpes. Annals of Internal Medicine, 116(3), 197–202.
Nilsen, A. E., Aasen, T., Halsos, A. M., Kinge, B. R., & Fiddian, A. P. (1982). Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. The Lancet.
Patel, R. (2008). Making the most of episodic antiviral therapy for genital herpes. Sexual Health, 5(3), 213–214.
Peacock, J., Kaplowitz, L., Sparling, P., Durack, D., Gnann, J., Whitley, R., … & Friedman-kien, A. (1988). Intravenous acyclovir therapy of first episodes of genital herpes: A multicenter double-blind, placebo-controlled trial. The American Journal of Medicine, 85(3), 301-306.
Piperi, E., Papadopoulou, E., Georgaki, M., Dovrat, S., Bar Illan, M., Nikitakis, N., & Yarom, N. (2023). Management of HSV infections and antiviral resistance. Oral Diseases.
Pol, B., Daniel, G., Aaron, K. J., Cooper, C. K., Kodsi, S., & Paradis, S. (2017). Decline in genital shedding in the year after first clinical episode genital herpes simplex virus type 1. Sexually Transmitted Infections, 93, A24.
Raborn, G. W., & Grace, M. (2003). Recurrent herpes simplex labialis: selected therapeutic options. Journal, 69(8), 498–503.
Reynolds, S. (2009). Role of HSV-2 suppressive therapy for HIV prevention. Future Microbiology, 4(9), 1095–1097.
Schiffer, J., Abu-Raddad, L., Mark, K., Zhu, J., Selke, S., Magaret, A., Wald, A., & Corey, L. (2009). Frequent release of low amounts of herpes simplex virus from neurons: Results of a mathematical model. Science Translational Medicine, 1, 7ra16.
Schiffer, J., Mayer, B., Fong, Y., Swan, D., & Wald, A. (2014). Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. Journal of The Royal Society Interface, 11.
Schindl, A., & Neumann, R. (1999). Low-intensity laser therapy for recurrent herpes simplex: A randomized controlled trial. The Journal of Investigative Dermatology, 113(2), 221–223.
Schmid-Wendtner, M., & Korting, H. (2004). Penciclovir cream – Improved topical treatment for herpes simplex infections. Skin Pharmacology and Physiology, 17, 214–218.
Siegel, M. A. (2002). Diagnosis and management of recurrent herpes simplex infections. Journal of the American Dental Association, 133(9), 1245–1249.
Slomka, M., Emery, L., Munday, P., Moulsdale, M., & Brown, D. (1998). A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. Journal of Medical Virology.
Sobh, M., Morfin, F., Labussière, H., et al. (2013). Acyclovir-resistant HSV-1 and oral mucositis in stem cell transplant patients. Blood, 122, 1048.
Tang, I. T., & Shepp, D. (1992). HSV infections in cancer patients: Prevention and treatment. Oncology, 6(7), 101–110.
Tarchini, G. (2010). Asymptomatic herpes simplex virus type 2 shedding—potential pitfalls of broader testing and aggressive suppression. The Journal of Infectious Diseases, 202(6), 979.
Thayerin, S., Hamed, K., & Richwald, G. (2013). Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes. Reproductive Endocrinology, 92–94.
Webb, D., & Fife, K. (1987). Genital herpes simplex virus infections. Infectious Disease Clinics of North America, 1(1), 97–122.
Whitley, R., & Hook, E. (2022). Shedding Patterns of Genital Herpes Simplex Virus Infections. JAMA.
Wicaksono, I. K., Ridho, F., & Zakiawati, D. (2024). Atypical clinical manifestations of herpes simplex virus-1 infection. International Medical Case Reports Journal, 17, 933–937.
Zhang, M., Liu, Y., Wang, P., Guan, X., He, S., Luo, S., … & Hu, Q. (2015). HSV-2 Immediate-Early Protein US1 inhibits IFN-β production by suppressing association of IRF-3 with IFN-β promoter. The Journal of Immunology, 194, 3102–3115.
